Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.

C Leprince, S Cohen-Kaminsky… - … (Baltimore, Md.: 1950 …, 1990 - journals.aai.org
C Leprince, S Cohen-Kaminsky, S Berrih-Aknin, B Vernet-Der Garabedian, D Treton…
Journal of immunology (Baltimore, Md.: 1950), 1990journals.aai.org
Thymic cell populations from 12 patients displaying myasthenia gravis were submitted to a
phenotypic and functional study. Immunofluorescence analysis of thymic sections revealed
the presence in germinal centers of B lymphocytes expressing the B cell markers--CD19,
CD21, IgD, or IgM. After T cell and macrophage depletion of thymic single cell suspensions,
B cell-enriched populations were isolated. Enriched B cells expressed at variable levels
activation markers such as CD71, 4F2, CD23, and B8. 7, indicating that a marked proportion …
Abstract
Thymic cell populations from 12 patients displaying myasthenia gravis were submitted to a phenotypic and functional study. Immunofluorescence analysis of thymic sections revealed the presence in germinal centers of B lymphocytes expressing the B cell markers--CD19, CD21, IgD, or IgM. After T cell and macrophage depletion of thymic single cell suspensions, B cell-enriched populations were isolated. Enriched B cells expressed at variable levels activation markers such as CD71, 4F2, CD23, and B8.7, indicating that a marked proportion of them are activated. Moreover, addition of B cell growth factor 12kDa and to a lesser extent of rIL-2 induced a spontaneous proliferation of these B cell populations. These functional and phenotypic signs of activation may reveal the first steps of an autoimmune response against acetylcholine receptor as enriched B cell populations have the capacity to spontaneously secrete anti-acetylcholine receptor antibody.
journals.aai.org